IP Library Granted Patent US 7,141,651
Granted Patent B2
US 7,141,651 · App. 10/603,064 · Granted Nov 28, 2006

Multiple cytokine protein complexes

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,141,651
App. No.
10/603,064
Granted
Nov 28, 2006
Kind
B2
Abstract

The invention relates to protein complexes and fusion proteins including at least two different cytokine molecules. The protein complexes and fusion proteins may further include a targeting moiety such as a region of an immunoglobulin. Methods of using the protein complexes and fusion proteins are also disclosed.

Claims (36)

1. A fusion protein comprising:

a first polypeptide chain comprising the p35 subunit of interleukin-12 (IL-12); and

a second polypeptide chain comprising a cytokine and the p40 subunit of IL-12, wherein the cytokine is a four-helix bundle protein.

2. The fusion protein of claim 1 , wherein the first polypeptide chain is covalently bonded to the second polypeptide chain.

3. The fusion protein of claim 2 , wherein the first polypeptide chain is covalently bonded to the second polypeptide chain by a disulfide bond.

4. The fusion protein of claim 1 , wherein the cytokine is interleukin-2 (IL-2).

5. The fusion protein of claim 1 , wherein the cytokine is granulocyte-macrophage colony stimulating factor (GM-CSF).

6. The fusion protein of claim 1 , wherein the cytokine is selected from the group consisting of interleukin-4 (IL-4), interleukin-6 (IL-6), and macrophage colony-stimulating factor (M-CSF).

7. A nucleic acid encoding the fusion protein of claim 1 .

8. An isolated or cultured cell comprising the nucleic acid of claim 7 .

9. A nucleic acid encoding the fusion protein of claim 4 .

10. An isolated or cultured cell comprising the nucleic acid of claim 9 .

11. A fusion protein comprising a single-chain polypeptide comprising:

the p35 subunit of interleukin-12 (IL-12);

the p40 subunit of IL-12; and

a second cytokine, wherein the second cytokine is a four-helix bundle protein, and wherein the p35 subunit of IL-12, the p40 subunit of IL-12, and the second cytokine are fused together as portions of a single, expressed polypeptide chain.

12. The fusion protein of claim 11 , wherein the second cytokine is interleukin-2 (IL-2).

13. The fusion protein of claim 11 , wherein the second cytokine is granulocyte-macrophage colony stimulating factor (GM-CSF).

14. The fusion protein of claim 11 , wherein the second cytokine is selected from the group consisting of interleukin-4 (IL-4), interleukin-6 (IL-6), and macrophage colony-stimulating factor (M CSF).

15. A nucleic acid encoding the fusion protein of claim 11 .

16. An isolated or cultured cell comprising the nucleic acid of claim 15 .

17. The fusion protein of claim 11 comprising, in an N- to C-terminal direction, the p35 subunit of IL-12, the p40 subunit of IL-12, and the second cytokine.

18. A nucleic acid encoding the fusion protein of claim 12 .

19. An isolated or cultured cell comprising the nucleic acid of claim 18 .

20. A fusion protein comprising:

a first polypeptide chain comprising the p40 subunit of interleukin-12 (IL-12); and

a second polypeptide chain comprising a cytokine and the p35 subunit of IL-12, wherein the cytokine is a four-helix bundle protein.

21. The fusion protein of claim 20 , wherein the first polypeptide chain is covalently bonded to the second polypeptide chain.

22. The fusion protein of claim 21 , wherein the first polypeptide chain is covalently bonded to the second polypeptide chain by a disulfide bond.

23. The fusion protein of claim 20 , wherein the cytokine is interleukin-2 (IL-2).

24. The fusion protein of claim 20 , wherein the cytokine is granulocyte-macrophage colony stimulating factor (GM-CSF).

25. The fusion protein of claim 20 , wherein the cytokine is selected from the group consisting of interleukin-4 (IL-4), interleukin-6 (IL-6), and macrophage colony-stimulating factor (M-CSF).

26. A nucleic acid encoding the fusion protein of claim 20 .

27. An isolated or cultured cell comprising the nucleic acid of claim 26 .

28. A nucleic acid encoding the fusion protein of claim 23 .

29. An isolated or cultured cell comprising the nucleic acid of claim 28 .

Assignments (5)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 24, 2008
From: EMD SERONO RESEARCH CENTER, INC.
To: MERCK PATENT GMBH
Reel/Frame 021138/0674 →
CHANGE OF NAME Recorded May 20, 2008
From: EMD LEXIGEN RESEARCH CENTER CORP.
To: EMD SERONO RESEARCH CENTER, INC.
Reel/Frame 020963/0382 →
CORRECTED COVER SHEET PREVIOUSLY RECORDED ON REEL 014663 FRAME 0092. Recorded Aug 27, 2004
From: GILLIES, STEPHEN D.; LO, KIN-MING
To: LEXIGEN PHARMACEUTICALS CORP.
Reel/Frame 015733/0236 →
CHANGE OF NAME Recorded Dec 19, 2003
From: LEXIGEN PHARMACEUTICALS, CORP.
To: EMD LEXIGEN RESEARCH CENTER CORP.
Reel/Frame 014815/0751 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 5, 2003
From: GILLIES, STEPHEN; LO, KIN-MING
To: LEXIGEN PHARMACEUTICALS CORP.
Reel/Frame 014663/0092 →